The Impact of Natural Compounds on the Treatment of Neurodegenerative Diseases
Journal:
Current Organic Chemistry
Volume:
23
Page:
335-360
Author(s):
Lorane I. da S. Hage-Melim*, Jaderson V. Ferreira, Nayana K.S. de Oliveira, Lenir C. Correia, Marcos R.S. Almeida, João G.C. Poiani, Carlton A. Taft and Carlos H.T. de Paula da Silva
AMPK in Neurodegenerative Diseases: Implications and Therapeutic Perspectives
Journal:
Current Drug Targets
Volume:
17
Page:
890-907
Author(s):
Claudia Marinangeli, Sébastien Didier and Valérie Vingtdeux
Histone Acetylation as a Potential Therapeutic Target in Motor Neuron Degenerative Diseases
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
5093-5104
Author(s):
Lutz Garbes, Markus Riessland and Brunhilde Wirth
At the “Junction” of Spinal Muscular Atrophy Pathogenesis: The Role of Neuromuscular Junction Dysfunction in SMA Disease Progression
Journal:
Current Molecular Medicine
Volume:
13
Page:
1160-1174
Author(s):
B. B. Goulet, R. Kothary and R. J. Parks
Apoptosis: A Key in Neurodegenerative Disorders
Journal:
Current Neurovascular Research
Volume:
1
Page:
355-371
Author(s):
Oleksandr Ekshyyan and Tak Yee Aw
Editorial [Hot topic: Central and Peripheral Metabolic Changes in Neurodegenerative Diseases (Guest Editor: Ana Cristina Rego)]
Journal:
Current Drug Targets
Volume:
11
Page:
1192-1192
Author(s):
Ana Cristina Rego
Transforming Growth Factor-β Signaling in Motor Neuron Diseases
Journal:
Current Molecular Medicine
Volume:
11
Page:
48-56
Author(s):
M. Katsuno, H. Adachi, H. Banno, K. Suzuki, F. Tanaka and G. Sobue